Prestige Consumer Healthcare (PBH) Current Deferred Tax Assets (2011 - 2018)
Prestige Consumer Healthcare's (PBH) quarterly Current Deferred Tax Assets came in at $26000.0 in Q1 2018, down 99.79% quarter-over-quarter from $12.6 million in Q4 2016.
Prestige Consumer Healthcare (PBH) Current Deferred Tax Assets (2011 - 2018) Analysis & Trends
Prestige Consumer Healthcare's Current Deferred Tax Assets history runs 7 years deep, the most recent figure standing at $26000.0 for Q1 2018.
- On a quarterly basis, Current Deferred Tax Assets changed N/A year-over-year to $26000.0 in Q1 2018; TTM through Mar 2018 was $26000.0, a N/A change from a year earlier, with the FY2018 full-year figure at $26000.0, changed N/A from the prior year.
- Current Deferred Tax Assets slipped to $26000.0 in Q1 2018 per PBH's latest filing, from $12.6 million in the prior quarter.
- Across five years, Current Deferred Tax Assets topped out at $12.6 million in Q4 2016 and bottomed at $26000.0 in Q1 2018.
- The 4-year median for Current Deferred Tax Assets is $8.3 million (2014), against an average of $8.2 million.
- Across the five-year window, Current Deferred Tax Assets dropped 9.79% in 2015 and surged 49.92% in 2016, its largest moves.
- Year by year, Current Deferred Tax Assets stood at $8.3 million in 2014, then rose by 0.72% to $8.4 million in 2015, then surged by 49.92% to $12.6 million in 2016, then plunged by 99.79% to $26000.0 in 2018.
- Per Business Quant, the three latest PBH Current Deferred Tax Assets figures stand at $26000.0 (Q1 2018), $12.6 million (Q4 2016), and $10.6 million (Q3 2016).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Prestige Consumer Healthcare | 2.34 Bn | 2.28 Bn | 157.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 26,000.00 |
| Mar 31, 2018 | 26,000.00 |
| Dec 31, 2016 | 12.60 Mn |
| Dec 31, 2016 | 12.60 Mn |
| Sep 30, 2016 | 10.65 Mn |
| Sep 30, 2016 | 10.65 Mn |
| Jun 30, 2016 | 10.70 Mn |
| Jun 30, 2016 | 10.70 Mn |
| Mar 31, 2016 | 10.11 Mn |
| Mar 31, 2016 | 10.11 Mn |
| Dec 31, 2015 | 8.41 Mn |
| Dec 31, 2015 | 8.41 Mn |
| Sep 30, 2015 | 8.27 Mn |
| Sep 30, 2015 | 8.27 Mn |
| Jun 30, 2015 | 7.92 Mn |
| Jun 30, 2015 | 7.92 Mn |
| Mar 31, 2015 | 8.10 Mn |
| Mar 31, 2015 | 8.10 Mn |
| Dec 31, 2014 | 8.35 Mn |
| Dec 31, 2014 | 8.35 Mn |